Literature DB >> 19968017

Unsuccessful suicide attempt of a 15 year old adolescent with ingestion of 5000 mg modafinil.

Gal Neuman1, Naim Shehadeh, Giora Pillar.   

Abstract

Modafinil (Provigil) is a wake-promoting drug approved for patients with narcolepsy or other causes of excessive daytime sleepiness. Each pill is 100 to 200 mg; maximal daily dose of modafinil in adults is 400 mg (the medication is not approved by the FDA for children younger than 16 years of age). We report the case of an adolescent who attempted to commit suicide by ingesting 50 pills of modafinil. The medication was prescribed for her mother to treat symptoms associated with multiple sclerosis. Approximately 2 hours following ingestion the patient complained of headache, nausea and abdominal pain. Her ECG demonstrated prolonged QTc interval. Observation for 72 hours revealed 24 hours of inability to sleep, tachycardia, and dyskinesia. There was no deterioration of kidney or liver functions, and no change in complete blood count or blood pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968017      PMCID: PMC2725258     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  4 in total

Review 1.  A systematic review of modafinil: Potential clinical uses and mechanisms of action.

Authors:  Jacob S Ballon; David Feifel
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Evaluation of the safety of modafinil for treatment of excessive sleepiness.

Authors:  Thomas Roth; Jonathan R L Schwartz; Max Hirshkowitz; Milton K Erman; Jeffrey M Dayno; Sanjay Arora
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

3.  Toxicity from modafinil ingestion.

Authors:  Henry A Spiller; Douglas Borys; Jill R K Griffith; Wendy Klein-Schwartz; Alfred Aleguas; Dawn Sollee; Deborah A Anderson; Tama S Sawyer
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

Review 4.  Approved and investigational uses of modafinil : an evidence-based review.

Authors:  Raminder Kumar
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  4 in total
  2 in total

Review 1.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

2.  Hyponatraemia and cerebral oedema due to a modafinil overdose.

Authors:  Rohan Oliver Kandasamy; Viktorija Kaminskaite; Felix May
Journal:  BMJ Case Rep       Date:  2020-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.